Apolipoprotein E polymorphisms and sleep quality in Obstructive Sleep Apnea Syndrome

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2223-2227

  Pellegrino, R ^a   Mazzotti, D R ^a   Guindalini, C ^a   Santos Silva, R ^a   Bittencourt, L R A ^a   Tufik, S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apolipoprotein E; Decreased sleep quality; Obstructive Sleep Apnea Syndrome; Polysomnography; Single nucleotide polymorphism; Sleep

Indexed keywords

APOLIPOPROTEIN E;

AGE DISTRIBUTION; APOE EPSILON 2 GENE; APOE EPSILON 3 GENE; APOE EPSILON 4 GENE; ARTICLE; BRAZIL; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; POLYSOMNOGRAPHY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX RATIO; SLEEP; SLEEP APNEA SYNDROME; SLEEP PARAMETERS; SLEEP QUALITY;

ALLELES; APOLIPOPROTEIN E2; HUMANS; POLYMORPHISM, GENETIC; POLYSOMNOGRAPHY; SLEEP; SLEEP APNEA, OBSTRUCTIVE;

EID: 80053639276     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.08.007     Document Type: Article

References (33)

1. Tufik S., Santos-Silva R., Taddei J.A., Bittencourt L.R. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010, 11:441-446.
2. Bliwise D.L. Sleep apnea, APOE4 and Alzheimer's disease 20years and counting?. J Psychosom Res 2002, 53:539-546.
3. Caselli R.J. Obstructive sleep apnea, apolipoprotein E e4, and mild cognitive impairment. Sleep Med 2008, 9:816-817.
4. Cosentino F.I., Bosco P., Drago V., et al. The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea. Sleep Med 2008, 9:831-839.
5. Foley D., Masaki K., White L., Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAMA 2001, 286:1447-1448.
6. Gottlieb D.J., DeStefano A.L., Foley D.J., et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 2004, 63:664-668.
7. Gozal D., Capdevila O.S., Kheirandish-Gozal L., Crabtree V.M. APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology 2007, 69:243-249.
8. Kadotani H., Kadotani T., Young T., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001, 285:2888-2890.
9. Larkin E.K., Patel S.R., Redline S., Mignot E., Elston R.C., Hallmayer J. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol 2006, 30:101-110.
10. Saarelainen S., Lehtimaki T., Kallonen E., Laasonen K., Poussa T., Nieminen M.M. No relation between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet 1998, 53:147-148.
11. Mendes-Lana A., Pena G.G., Freitas S.N., et al. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. Braz J Med Biol Res 2007, 40:49-56. et al.
12. Kheirandish L., Row B.W., Li R.C., Brittian K.R., Gozal D. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 2005, 28:1412-1417.
13. Das H.K., McPherson J., Bruns G.A., Karathanasis S.K., Breslow J.L. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985, 260:6240-6247.
14. Craig D., Hart D.J., Passmore A.P. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006, 29:1003-1007.
15. Thakre T.P., Mamtani M.R., Kulkarni H. Lack of association of the APOE epsilon 4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regression. Sleep 2009, 32:1507-1511.
16. Verma A., Radtke R.A., VanLandingham K.E., King J.H., Husain A.M. Slow wave sleep rebound and REM rebound following the first night of treatment with CPAP for sleep apnea: correlation with subjective improvement in sleep quality. Sleep Med 2001, 2:215-223.
17. Santos-Silva R., Tufik S., Conway S.G., Taddei J.A., Bittencourt L.R. Sao Paulo Epidemiologic Sleep Study: rationale, design, sampling, and procedures. Sleep Med 2009, 10:679-685.
18. Rechtschaffen A., Kales A. A Manual of standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects 1968, Brain Information Service/Brain Research Institute, Los Angeles. 1st ed.
19. Westchester I. American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual (ICSD-2) 2005, 2nd ed.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
21. Falush D., Stephens M., Pritchard J.K. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003, 164:1567-1587.
22. Guindalini C., Colugnati F.A., Pellegrino R., Santos-Silva R., Bittencourt L.R., Tufik S. Influence of genetic ancestry on the risk for Obstructive Sleep Apnoea Syndrome. Eur Respir J. 2010 Oct, 36(4):834-841.
23. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
24. De Blasi S., Montesanto A., Martino C., et al. APOE polymorphism affects episodic memory among non demented elderly subjects. Exp Gerontol 2009, 44:224-227.
25. Jun J, Reinke C, Bedja D, et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis; 209:381-386.
26. Agosta F., Vossel K.A., Miller B.L., et al. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A 2009, 106:2018-2022.
27. Guang-da X., Xiang-Jiu Y., Lin-Shuang Z., Zhi-Song C., Yu-Sheng H. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change. Diabetes Res Clin Pract 2005, 68:223-229.
28. Huang Y. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases. Curr Opin Lipidol 2010, 21:337-345.
29. Kulminski A.M., Ukraintseva S.V., Arbeev K.G., et al. Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men. J Am Geriatr Soc 2008, 56:478-483.
30. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009, 8:464-474.
31. Huang X., Chen P.C., Poole C. APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 2004, 62:2198-2202.
32. Mahley R.W., Rall S.C., Apolipoprotein E. Apolipoprotein E: far more than a lipid transport protein. Annual review of genomics and human genetics. Annu Rev Genomics Hum Genet 2000, 1:507-537.
33. Elshourbagy N.A., Liao W.S., Mahley R.W., Taylor J.M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 1985, 82:203-207.